AQEMIA vs Evozyne
AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI
87 employees · est. 2019 · Paris, France
Evozyne
Generative AI-powered drug discovery platform and product development
54 employees · est. 2020 · Chicago, United States
AQEMIA is the older company (2019 vs 2020).
6 signals in the last 90 days
Side-by-Side Comparison
| Metric | AQEMIA | Evozyne |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2020 |
| Headquarters | ||
| Headquarters | Paris, France | Chicago, United States |
| Employees | ||
| Employees | 87 | 54 |
| Industry | ||
| Industry | AI, Biotechnology, Life Sciences | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series B |
| Total Funding | ||
| Total Funding | $115.18M | $144.36M |
| Funding Rounds | ||
| Funding Rounds | 7 | 4 |
| Services | ||
| Services | AI-driven drug discovery, Development of next-generation medicines | AI-native Protein Design, Protein Synthesis and Testing, Therapeutic Protein Development, Immunology Pipeline Advancement |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotech researchers, Healthcare providers | Patients with High Unmet Need in Immune-Mediated Diseases, Healthcare Providers, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Drug DiscoveryQuantum-inspired PhysicsGenerative AIPharmaceutical R&DTechBioPharmaTech +8 | Generative AIDrug DiscoveryProtein DesignTherapeutic DiscoveryMolecular ScaleNovel Protein Therapeutics +5 |
| Website | ||
| Website | aqemia.com | evozyne.com |
About AQEMIA
AQEMIA, founded in 2019, is a cutting-edge company at the intersection of AI and biotechnology, focusing on drug discovery through the use of quantum-inspired physics and generative AI. The company specializes in creating novel medicines to address significant diseases, particularly in the oncology...
About Evozyne
Evozyne, founded in 2020, is at the forefront of the Biotechnology and Pharmaceutical industries with its innovative approach to drug development. The company's slogan, "Generative AI-powered drug discovery platform and product development," encapsulates its mission to design novel protein therapeut...
Also comparing in this category
Comparing more than these two?
Get AQEMIA, Evozyne and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does AQEMIA compare?
A PDF of AQEMIA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare AQEMIA with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at AQEMIA on 15 Jun 2026, and Evozyne on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
